©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 933-944
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.933
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.933
Table 1 Preoperative characteristics of 45 patients with rectal cancer who underwent transanal endoscopic intersphincteric resection
| Characteristic | Data |
| Sex | |
| Female | 16 (35.56) |
| Male | 29 (64.44) |
| Age in yr | 57.91 ± 12.571 |
| BMI in kg/m2 | 23.39 ± 3.41 |
| Weight in kg | 64.13 ± 11.40 |
| Hight in cm | 163.93 ± 6.93 |
| Hypertension | 9 (20.00) |
| Diabetic | 6 (13.33) |
| ASA grading | |
| I | 4 (8.89) |
| II | 33 (73.33) |
| III | 8 (17.78) |
| Neoadjuvant chemoradiotherapy | |
| No | 33 (73.33) |
| Yes | 12 (26.67) |
| Height from anal verge in cm | 3.87 (2.50-5.00) |
- Citation: Xu ZW, Zhu JT, Bai HY, Yu XJ, Hong QQ, You J. Clinical efficacy and pathological outcomes of transanal endoscopic intersphincteric resection for low rectal cancer. World J Gastrointest Oncol 2024; 16(3): 933-944
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/933.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.933